

Fractyl Health, a developer of treatments aimed at reversing the metabolic disease epidemic, has secured $100 million in Series F financing. Maverick Capital, M28 Capital, and Population Health Partners led the round.
Source: Press Release
Fractyl Health, a developer of treatments aimed at reversing the metabolic disease epidemic, has secured $100 million in Series F financing.
Fractyl Health, a developer of treatments aimed at reversing the metabolic disease epidemic, has secured $100 million in Series F financing. Maverick Capital, M28 Capital, and Population Health Partners led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination